Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CLOV Clover Health Investments Corp
- Stocks
- Healthcare
- NASDAQ: CLOV
Price (delayed)
$2.75
Market cap
$1.4B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.05
Enterprise value
$1.24B
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral
Highlights
The debt has plunged by 100% YoY
CLOV's EPS has surged by 84% year-on-year and by 44% since the previous quarter
Clover Health Investments's quick ratio has decreased by 23% QoQ and by 21% YoY
Key stats
What are the main financial stats of CLOV
Market
Valuations
Earnings
Shares outstanding
508.92M
Market cap
$1.4B
Enterprise value
$1.24B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.18
Price to sales (P/S)
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.84
Revenue
$1.49B
Gross profit
$391.93M
Operating income
-$24.32M
Net income
-$25.11M
EBIT
-$25.11M
EBITDA
-$23.63M
Free cash flow
-$8.68M
Per share
Balance sheet
Liquidity
EPS
-$0.05
EPS diluted
-$0.05
Free cash flow per share
-$0.02
Book value per share
$0.66
Revenue per share
$2.99
TBVPS
$1.17
Total assets
$583.72M
Total liabilities
$247.64M
Debt
$0
Equity
$336.08M
Working capital
$115.76M
Debt to equity
0
Current ratio
1.54
Quick ratio
0.99
Net debt/EBITDA
6.58
Margins
Efficiency
Dividend
EBITDA margin
-1.6%
Gross margin
26.4%
Net margin
-1.7%
Operating margin
-1.6%
Return on assets
-4%
Return on equity
-7.5%
Return on invested capital
-17.9%
Return on capital employed
-6.8%
Return on sales
-1.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLOV stock price
How has the Clover Health Investments stock price performed over time
Intraday
-1.43%
1 week
-3.17%
1 month
-12.42%
1 year
129.17%
YTD
-12.7%
QTD
-1.43%
Financial performance
How have Clover Health Investments's revenue and profit performed over time
Revenue
$1.49B
Gross profit
$391.93M
Operating income
-$24.32M
Net income
-$25.11M
Gross margin
26.4%
Net margin
-1.7%
Clover Health Investments's operating margin has soared by 86% YoY and by 52% from the previous quarter
The net margin has soared by 86% YoY and by 45% from the previous quarter
The operating income has soared by 84% YoY and by 47% from the previous quarter
The net income has soared by 84% year-on-year and by 42% since the previous quarter
Price vs fundamentals
How does CLOV's price correlate with its fundamentals
Growth
What is Clover Health Investments's growth rate over time
Valuation
What is Clover Health Investments stock price valuation
P/E
N/A
P/B
4.18
P/S
0.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.84
CLOV's EPS has surged by 84% year-on-year and by 44% since the previous quarter
The equity has grown by 15% YoY
The P/B is 9% above the 5-year quarterly average of 3.9 and 6% above the last 4 quarters average of 4.0
The P/S is 66% below the 5-year quarterly average of 2.7 and 7% below the last 4 quarters average of 1.0
The revenue has grown by 16% YoY and by 8% from the previous quarter
Efficiency
How efficient is Clover Health Investments business performance
The return on invested capital has surged by 90% year-on-year and by 52% since the previous quarter
CLOV's ROE has soared by 86% YoY and by 43% from the previous quarter
CLOV's return on sales has surged by 86% year-on-year and by 45% since the previous quarter
The ROA has soared by 78% YoY and by 40% from the previous quarter
Dividends
What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLOV.
Financial health
How did Clover Health Investments financials performed over time
CLOV's total assets is 136% greater than its total liabilities
Clover Health Investments's total liabilities has decreased by 35% YoY but it has increased by 3.4% from the previous quarter
Clover Health Investments's quick ratio has decreased by 23% QoQ and by 21% YoY
The debt is 100% less than the equity
The debt has plunged by 100% YoY
The debt to equity has plunged by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.